At 90 days , 448 patients ( 37.0 % ) in the fresh-blood group and 430 patients ( 35.3 % ) in the standard-blood group had died ( absolute risk difference , 1.7 percentage points ; 95 % confidence interval [ CI ] , -2.1 to 5.5 ) .